The pressure to maintain low prices for medicines is an issue for all pharma giants, especially in Europe, where government cost-containment policies have helped depress company sales and thus profits. ???Pricing pressure in Europe adversely impacted underlying growth in the region by approximately five percentage points (approximately ??320 million) during 2011.